Armillei, M.K.; Lomakin, I.B.; Del Rosso, J.Q.; Grada, A.; Bunick, C.G.
Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics 2024, 13, 270.
https://doi.org/10.3390/antibiotics13030270
AMA Style
Armillei MK, Lomakin IB, Del Rosso JQ, Grada A, Bunick CG.
Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics. 2024; 13(3):270.
https://doi.org/10.3390/antibiotics13030270
Chicago/Turabian Style
Armillei, Maria K., Ivan B. Lomakin, James Q. Del Rosso, Ayman Grada, and Christopher G. Bunick.
2024. "Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease" Antibiotics 13, no. 3: 270.
https://doi.org/10.3390/antibiotics13030270
APA Style
Armillei, M. K., Lomakin, I. B., Del Rosso, J. Q., Grada, A., & Bunick, C. G.
(2024). Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics, 13(3), 270.
https://doi.org/10.3390/antibiotics13030270